Cargando…

Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics

Inflammatory bowel disease (IBD) is a chronic and heterogeneous intestinal inflammatory disorder. The medical management of IBD aims for long-lasting disease remission to prevent complications and disease progression. Early introduction of immunosuppression forms the mainstay of medical IBD manageme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voskuil, Michiel Dirk, Bangma, Amber, Weersma, Rinse Karel, Festen, Eleonora Anna Margaretha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Opinion Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558438/ https://www.ncbi.nlm.nih.gov/pubmed/31210708 http://dx.doi.org/10.3748/wjg.v25.i21.2539

Ejemplares similares

Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease
por: Bangma, Amber, et al.
Publicado: (2020)

TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease
por: Bangma, Amber, et al.
Publicado: (2021)

Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFα therapy in inflammatory bowel disease
por: Karmi, Naomi, et al.
Publicado: (2021)

Environmental factors associated with biological use and surgery in inflammatory bowel disease
por: van der Sloot, Kimberley W J, et al.
Publicado: (2020)

Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease
por: Hu, Shixian, et al.
Publicado: (2021)

Large-scale genetic analyses in an understudied disease: haemorrhoidal disease
por: Festen, Eleonora A M, et al.
Publicado: (2021)

Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease
por: van der Sloot, Kimberley W J, et al.
Publicado: (2020)

Towards the clinical implementation of pharmacogenetics in bipolar disorder
por: Salloum, Naji C, et al.
Publicado: (2014)

The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease
por: Ruigrok, Renate A A A, et al.
Publicado: (2021)

Understanding human gut diseases at single-cell resolution
por: Bigaeva, Emilia, et al.
Publicado: (2020)

The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R, et al.
Publicado: (2021)

Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Development and validation of a web-based questionnaire to identify environmental risk factors for inflammatory bowel disease: the Groningen IBD Environmental Questionnaire (GIEQ)
por: van der Sloot, Kimberley Wilhelmina Johanna, et al.
Publicado: (2018)

Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease
por: Spekhorst, Lieke M, et al.
Publicado: (2017)

A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects
por: Collij, Valerie, et al.
Publicado: (2019)

Gut microbiota in inflammatory bowel diseases: moving from basic science to clinical applications
por: Collij, Valerie, et al.
Publicado: (2020)

Genetic Association Analysis of the Functional c.714T>G Polymorphism and Mucosal Expression of Dectin-1 in Inflammatory Bowel Disease
por: de Vries, Hilbert S., et al.
Publicado: (2009)

Donor tobacco smoking is associated with postoperative thrombosis after primary liver transplantation
por: Li, Yanni, et al.
Publicado: (2020)

Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease
por: Otten, Antonius T., et al.
Publicado: (2022)

Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab
por: Loveikyte, Roberta, et al.
Publicado: (2023)

Donepezil in Alzheimer’s disease: From conventional trials to pharmacogenetics
por: Cacabelos, Ramón
Publicado: (2007)

Immunomodulatory and Anti-Inflammatory Phytochemicals for the Treatment of Inflammatory Bowel Disease (IBD): - Turning Strong Rationale into Strong Evidence? -
por: Sodagari, Hamid Reza, et al.
Publicado: (2018)

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease
por: Gacesa, R., et al.
Publicado: (2021)

Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn’s Disease Exacerbations
por: Klaassen, Marjolein A Y, et al.
Publicado: (2019)

Pharmacogenetics of antipsychotic-induced side effects
por: Lencz, Todd, et al.
Publicado: (2009)

Review of inflammatory bowel disease and COVID-19
por: Sultan, Keith, et al.
Publicado: (2020)

Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease
por: Curci, Debora, et al.
Publicado: (2021)

Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease Phenotypes
por: Voskuil, M D, et al.
Publicado: (2020)

Completion rate of small bowel capsule endoscopy is higher after erythromycin compared to domperidone
por: Westerhof, Jessie, et al.
Publicado: (2014)

A Dutch Perspective on Two Health Related Issues Regarding Children and Adolescents with Intellectual Disabilities
por: Moonen, Xavier, et al.
Publicado: (2022)

The Emergence of Endophytic Microbes and Their Biological Promise
por: Strobel, Gary
Publicado: (2018)

The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1
por: Imhann, Floris, et al.
Publicado: (2019)

Let's Look on the Bright Side of ChatGPT
por: Yoo, Jin-Hong
Publicado: (2023)

Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome‐wide association study
por: Li, Yanni, et al.
Publicado: (2021)

Commercial antibodies and their validation
por: Voskuil, JLA
Publicado: (2014)

How difficult is the validation of clinical biomarkers?
por: Voskuil, Jan
Publicado: (2015)

Genetic effects on the commensal microbiota in inflammatory bowel disease patients
por: Aschard, Hugues, et al.
Publicado: (2019)

Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies
por: Yamamoto-Furusho, Jesús K
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_09hffch4oga2ok8qskh7fc3s8l